Premium
Overcoming melanoma drug resistance through metabolic targeting?
Author(s) -
Smalley Keiran S. M.
Publication year - 2013
Publication title -
pigment cell and melanoma research
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.618
H-Index - 105
eISSN - 1755-148X
pISSN - 1755-1471
DOI - 10.1111/pcmr.12154
Subject(s) - neuroblastoma ras viral oncogene homolog , melanoma , mek inhibitor , cancer research , trametinib , pten , vemurafenib , targeted therapy , dabrafenib , mapk/erk pathway , medicine , pi3k/akt/mtor pathway , protein kinase b , cancer , kinase , signal transduction , biology , kras , genetics , metastatic melanoma , colorectal cancer
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom